Clinical Radiology
Volume 63, Issue 1 , Pages 1-11 , January 2008

Imaging appearances following thermal ablation

  • S. Smith
    • ,
  • A. Gillams

      Affiliations

    • Corresponding Author InformationGuarantor and correspondent: A. Gillams, Special Xray, Podium 2, University College Hospital, 235, Euston Road, London NW1 2BU, UK. Tel./fax: +44 207 380 9483.

Received 31 March 2007 ,Revised 4 June 2007 ,Accepted 8 June 2007.

References 

  1. Livraghi T, Solbiati L, Meloni MF, et al. Treatment of focal liver tumors with percutaneous radio-frequency ablation: complications encountered in a multicenter study. Radiology. 2003;226:441–451
  2. Yasui K, Shimizu Y. Surgical treatment for metastatic malignancies. Anatomical resection of liver metastasis: indications and outcomes. Int J Clin Oncol. 2005;10:86–96
  3. Livraghi T, Sangalli G, Vettori C. Adenomatous hyperplastic nodules in the cirrhotic liver: a therapeutic approach. Work in progress. Radiology. 1989;170:155–157
  4. Steger AC, Lees WR, Walmsley K, et al. Interstitial laser hyperthermia: a new approach to local destruction of tumours. BMJ. 1989;299:362–365
  5. McGahan JP, Browning PD, Brock JM, et al. Hepatic ablation using radiofrequency electrocautery. Invest Radiol. 1990;25:267–270
  6. Rossi S, Fornari F, Pathies C, et al. Thermal lesions induced by 480 KHz localized current field in guinea pig and pig liver. Tumori. 1990;76:54–57
  7. Gillams AR. The use of radiofrequency in cancer. Br J Cancer. 2005;92:1825–1829
  8. Solbiati L, Livraghi T, Goldberg SN, et al. Percutaneous radio-frequency ablation of hepatic metastases from colorectal cancer: long-term results in 117 patients. Radiology. 2001;221:159–166
  9. Gillams AR, Lees WR. Radio-frequency ablation of colorectal liver metastases in 167 patients. Eur Radiol. 2004;14:2261–2267
  10. Gillams AR, Lees WR. Survival after percutaneous, image-guided, thermal ablation of hepatic metastases from colorectal cancer. Dis Colon Rectum. 2000;43:656–661
  11. Jakobs TF, Hoffmann RT, Trumm C, et al. Radiofrequency ablation of colorectal liver metastases: mid-term results in 68 patients. Anticancer Res. 2006;26:671–680
  12. Livraghi T, Goldberg SN, Solbiati L, et al. Percutaneous radio-frequency ablation of liver metastases from breast cancer: initial experience in 24 patients. Radiology. 2001;220:145–149
  13. Lawes D, Chopada A, Gillams A, et al. Radiofrequency ablation (RFA) as a cytoreductive strategy for hepatic metastasis from breast cancer. Ann R Coll Surg Engl. 2006;88:639–642
  14. Gillams A, Cassoni A, Conway G, et al. Radiofrequency ablation of neuroendocrine liver metastases: the Middlesex experience. Abdom Imaging. 2005;30:435–441
  15. Ni Y, Mulier S, Miao Y, et al. A review of the general aspects of radiofrequency ablation. Abdom Imaging. 2005;30:381–400
  16. Goldberg SN, Gazelle GS, Compton CC, et al. Treatment of intrahepatic malignancy with radiofrequency ablation: radiologic–pathologic correlation. Cancer. 2000;88:2452–2463
  17. Hansen PD, Rogers S, Corless CL, et al. Radiofrequency ablation lesions in a pig liver model. J Surg Res. 1999;87:114–121
  18. Raman SS, Lu DS, Vodopich DJ, et al. Creation of radiofrequency lesions in a porcine model: correlation with sonography, CT, and histopathology. AJR Am J Roentgenol. 2000;175:1253–1258
  19. Vilana R, Llovet JM, Bianchi L, et al. Contrast-enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation. J Clin Ultrasound. 2003;31:119–128
  20. Wen YL, Kudo M, Zheng RQ, et al. Radiofrequency ablation of hepatocellular carcinoma: therapeutic response using contrast-enhanced coded phase-inversion harmonic sonography. AJR Am J Roentgenol. 2003;181:57–63
  21. Choi D, Lim HK, Rhim H, et al. Percutaneous radiofrequency ablation for recurrent hepatocellular carcinoma after hepatectomy: long-term results and prognostic factors. Ann Surg Oncol. 2007;
  22. Gillams A, Lees WR. Thermal ablation induced changes in hepatic arterial perfusion. Radiology. 1999;213P
  23. Tsuda M, Majima K, Yamada T, et al. Hepatocellular carcinoma after radiofrequency ablation therapy: dynamic CT evaluation of treatment. Clin Imaging. 2001;25:409–415
  24. Nghiem HV, Francis IR, Fontana R, et al. Computed tomography appearances of hypervascular hepatic tumors after percutaneous radiofrequency ablation therapy. Curr Probl Diagn Radiol. 2002;31:105–111
  25. Choi H, Loyer EM, DuBrow RA, et al. Radio-frequency ablation of liver tumors: assessment of therapeutic response and complications. RadioGraphics. 2001;21:S41–S54
  26. Berber E, Foroutani A, Garland AM, et al. Use of CT Hounsfield unit density to identify ablated tumor after laparoscopic radiofrequency ablation of hepatic tumors. Surg Endosc. 2000;14:799–804
  27. Chopra S, Dodd GD, Chintapalli KN, et al. Tumor recurrence after radiofrequency thermal ablation of hepatic tumors: spectrum of findings on dual-phase contrast-enhanced CT. AJR Am J Roentgenol. 2001;177:381–387
  28. Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst. 2000;92:205–216
  29. Dromain C, de Baere T, Elias D, et al. Hepatic tumors treated with percutaneous radio-frequency ablation: CT and MR imaging follow-up. Radiology. 2002;223:255–262
  30. Gillams AR. Complications of percutaneous therapy. Cancer Imaging. 2005;5:110–113
  31. Veit P, Antoch G, Stergar H, et al. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol. 2006;16:80–87
  32. Donckier V, Van Laethem JL, Goldman S, et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol. 2003;84:215–223
  33. Yamamoto A, Nakamura K, Matsuoka T, et al. Radiofrequency ablation in a porcine lung model: correlation between CT and histopathologic findings. AJR Am J Roentgenol. 2005;185:1299–1306
  34. Rossi S, Dore R, Cascina A, et al. Percutaneous computed tomography-guided radiofrequency thermal ablation of small unresectable lung tumours. Eur Respir J. 2006;27:556–563
  35. Steinke K, King J, Glenn D, et al. Radiologic appearance and complications of percutaneous computed tomography-guided radiofrequency-ablated pulmonary metastases from colorectal carcinoma. J Comput Assist Tomogr. 2003;27:750–757
  36. Bojarski JD, Dupuy DE, Mayo-Smith WW. CT imaging findings of pulmonary neoplasms after treatment with radiofrequency ablation: results in 32 tumors. AJR Am J Roentgenol. 2005;185:466–471
  37. Oyama Y, Nakamura K, Matsuoka T, et al. Radiofrequency ablated lesion in the normal porcine lung: long-term follow-up with MRI and pathology. Cardiovasc Intervent Radiol. 2005;28:346–353
  38. Okuma T, Matsuoka T, Okamura T, et al. 18F-FDG small-animal PET for monitoring the therapeutic effect of CT-guided radiofrequency ablation on implanted VX2 lung tumors in rabbits. J Nucl Med. 2006;47:1351–1358
  39. Okuma T, Okamura T, Matsuoka T, et al. Fluorine-18-fluorodeoxyglucose positron emission tomography for assessment of patients with unresectable recurrent or metastatic lung cancers after CT-guided radiofrequency ablation: preliminary results. Ann Nucl Med. 2006;20:115–121
  40. Akeboshi M, Yamakado K, Nakatsuka A, et al. Percutaneous radiofrequency ablation of lung neoplasms: initial therapeutic response. J Vasc Interv Radiol. 2004;15:463–470
  41. Crowley JD, Shelton J, Iverson AJ, et al. Laparoscopic and computed tomography-guided percutaneous radiofrequency ablation of renal tissue: acute and chronic effects in an animal model. Urology. 2001;57:976–980
  42. Zagoria RJ, Hawkins AD, Clark PE, et al. Percutaneous CT-guided radiofrequency ablation of renal neoplasms: factors influencing success. AJR Am J Roentgenol. 2004;183:201–207
  43. Arzola J, Baughman SM, Hernandez J, et al. Computed tomography-guided, resistance-based, percutaneous radiofrequency ablation of renal malignancies under conscious sedation at two years of follow-up. Urology. 2006;68:983–987
  44. Roy-Choudhury SH, Cast JE, Cooksey G, et al. Early experience with percutaneous radiofrequency ablation of small solid renal masses. AJR Am J Roentgenol. 2003;180:1055–1061
  45. Ogan K, Jacomides L, Dolmatch BL, et al. Percutaneous radiofrequency ablation of renal tumors: technique, limitations, and morbidity. Urology. 2002;60:954–958
  46. Gervais DA, McGovern FJ, Arellano RS, et al. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology. 2003;226:417–424
  47. Svatek RS, Sims R, Anderson JK, et al. Magnetic resonance imaging characteristics of renal tumors after radiofrequency ablation. Urology. 2006;67:508–512
  48. Sironi S, Livraghi T, Meloni F, et al. Small hepatocellular carcinoma treated with percutaneous RF ablation: MR imaging follow-up. AJR Am J Roentgenol. 1999;173:1225–1229

PII: S0009-9260(07)00262-0

doi: 10.1016/j.crad.2007.06.002

Clinical Radiology
Volume 63, Issue 1 , Pages 1-11 , January 2008

Article Tools

* Image Usage & Resolution